Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Viganego

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Blood|December 31, 2002
Factors affecting antibody levels after allogeneic hematopoietic cell transplantationJan Storek, Federico Viganego, Monja A Dawson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 24, 2012
Endovascular recanalization of central venous access to allow for pacemaker implantation or upgradeGabriel Maluenda, Francis Bustos, Federico Viganego, et al.
The American Journal of Cardiology|June 19, 2019
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic ChemotherapyMichael G Fradley, Matthew Gliksman, Josephine Emole, et al.
Heart (British Cardiac Society)|July 2, 2021
Association between ibrutinib treatment and hypertensionDae Hyun Lee, Fahad Hawk, Kieun Seok, et al.
Blood|April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyRichard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Blood|December 31, 2002
Factors affecting antibody levels after allogeneic hematopoietic cell transplantationJan Storek, Federico Viganego, Monja A Dawson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 24, 2012
Endovascular recanalization of central venous access to allow for pacemaker implantation or upgradeGabriel Maluenda, Francis Bustos, Federico Viganego, et al.
The American Journal of Cardiology|June 19, 2019
Rates and Risk of Atrial Arrhythmias in Patients Treated With Ibrutinib Compared With Cytotoxic ChemotherapyMichael G Fradley, Matthew Gliksman, Josephine Emole, et al.
Heart (British Cardiac Society)|July 2, 2021
Association between ibrutinib treatment and hypertensionDae Hyun Lee, Fahad Hawk, Kieun Seok, et al.
Blood|April 25, 2007
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyRichard A Nash, Peter A McSweeney, Leslie J Crofford, et al.
Pageof 2